Highlighted Article – Evaluation of Salivary Melatonin Levels in HIV- Positive Patients – Reviews on Recent Clinical Trials

RRCT-Articles_12-4-Fatemeh Ahmadi-Motamayel


HIV Treatment – Where Have the Researchers Reached?

HIV, Human Immunodeficiency Virus, has been the deadliest virus discovered in the last century. The virus is feared for its ability to affect the immune system of humans and render them vulnerable to catch any other virus, bacteria or disease that may be around. What’s worse is the contagious nature of HIV, as it can easily transmit through blood diffusion, sexual transmission, cuts and wounds, and also from mothers to babies. The virus has been extremely resistant to medicines and treatments so far, making it a veteran killer of humans.


There has been some recent advancement in administering drugs to HIV patients which have proven promising in keeping the virus from multiplying. Applauding this progress, the researchers have also apprehended that the virus is so resilient that it quickly alters itself through mutation to keep its onslaught going. The drugs can only hold the virus back temporarily and soon they lose their utility.

This has led the researchers to develop computational methods to track the changes occurring in HIV and realize when the right time to change the course of treatment comes. The method can also make the changes predictable and so the scientists will be able to proactively deal with the danger.

The research paper, Current Approaches in Computational Drug Resistance Prediction in HIV, published in Current HIV Research journal presents the study in detail.

%d bloggers like this: